체외 폐 모델 시장 규모는 향후 몇 년 동안 비약적인 성장을 보일 것으로 예상되며, 2029년에는 연평균 21.0%의 성장률로 11억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 의약품 개발 수요, 전임상시험의 증가, 호흡기 독성학에 대한 인식 증가, 재생의학에 대한 관심, 환경 문제에 대한 관심 증가, 노령 인구 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 의약품 검사 수요 증가, 3D 프린팅 기술 발전, 장기 온칩 기술 발전, AI와 머신러닝의 통합, 센서와 모니터링 기기의 통합, 의약품 이외의 용도 확대, 질병 특이적 모델 개발 등을 꼽을 수 있습니다.
임상시험의 급증은 향후 in vitro 폐 모델 시장의 성장을 촉진할 것으로 예상됩니다. 임상시험은 인간을 대상으로 새로운 의료 접근법의 효과를 평가하는 연구입니다. 이러한 임상 연구의 증가는 첨단 의료에 대한 수요 증가, 헬스케어 수요 증가, 복잡한 건강 문제에 대한 혁신적인 해결책 모색에 의해 촉진되고 있습니다. 시험관 내 폐 모델은 물질이 폐 조직에 어떤 영향을 미치는지 알아볼 수 있는 통제된 환경을 제공하고, 약물 테스트, 독성 평가, 질병 모델링, 질병 메커니즘을 이해하는 데 도움을 줌으로써 임상시험에서 중요한 역할을 하고 있습니다. 예를 들어, 미국 임상시험 등록기관인 ClinicalTrials.gov에 따르면, 2024년 1월 현재 전 세계적으로 47만 7,230건의 임상시험이 등록되어 있으며, 이는 2022년 43만 7,508건에서 증가한 수치입니다. 그 결과, 임상시험의 증가가 체외 폐 모델 시장을 자극하고 있습니다.
체외 폐 모델 시장의 주요 업체들은 생리적 관련성과 모델의 복잡성을 높이기 위해 3D 호흡기 조직 모델을 개발하고 있습니다. 이러한 모델은 선택된 호흡기 세포를 특수한 환경에서 배양하여 만들어지며, 호흡기의 기능과 형태를 모방한 3차원 구조를 형성할 수 있습니다. 이를 통해 연구 및 약물 시험에 보다 생리학적으로 적합한 플랫폼을 제공합니다. 예를 들어, 미국 소재 생명공학 기업 MatTek Corporation은 2023년 4월, 최초의 인간 비강 상피세포로 만든 혁신적인 3D 호흡기 조직 모델인 EpiNasal을 출시했습니다. EpiNasal의 도입은 MatTek의 3D 호흡기 조직 모델의 범위를 확장하여 의약품, 화학제품, 병원체 및 소비자 제품이 인체 호흡기에 미치는 영향을 연구할 수 있는 종합적인 시스템을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 체외 폐 모델 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 체외 폐 모델 시장 : 성장률 분석
- 세계의 체외 폐 모델 시장 실적 : 규모와 성장, 2019-2024
- 세계의 체외 폐 모델 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 체외 폐 모델 전체 시장(TAM)
제6장 시장 세분화
- 세계의 체외 폐 모델 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 2차원(2D) 모델
- 3차원(3D) 모델
- 세계의 체외 폐 모델 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- Drug Discovery와 독성학 연구
- 생리학적 조사
- 3차원(3D) 모델 개발
- 기타 용도
- 세계의 체외 폐 모델 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 학술조사기관
- 제약 및 바이오테크놀러지 기업
- 기타 최종사용자
- 세계의 체외 폐 모델 시장 2차원(2D) 모델 하위 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 단층 세포배양
- 공배양
- 세계의 체외 폐 모델 시장 3차원(3D) 모델 하위 세분화(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 구형 몸
- 오가노이드
- 폐on-chip 모델
제7장 지역별·국가별 분석
- 세계의 체외 폐 모델 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 체외 폐 모델 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 체외 폐 모델 시장 : 경쟁 구도
- 체외 폐 모델 시장 : 기업 개요
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
- PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
- Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Epithelix
- The Charles Stark Draper Laboratory Inc.
- STEMCELL Technologies
- American Type Culture Collection(ATCC)
- BioIVT
- InSphero
- Emulate Inc.
- PhoenixBio Co. Ltd.
- Newcells Biotech
- CN Bio Innovations Ltd.
- Mimetas
- Cyfuse Biomedical K.K.
- 3D Biotek LLC
- AlveoliX AG
- AxoSim Technologies LLC
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 체외 폐 모델 시장 2029 : 새로운 기회를 제공하는 국가
- 체외 폐 모델 시장 2029 : 새로운 기회를 제공하는 부문
- 체외 폐 모델 시장 2029 : 성장 전략
제36장 부록
ksm
An in vitro lung model is a scientific construct devised to replicate the cellular, structural, and functional characteristics of the human lung within a controlled laboratory setting. These models empower researchers to explore disease progression, identify biomarkers, and evaluate treatment effectiveness. They serve as invaluable instruments for advancing our comprehension of lung biology, refining therapeutic approaches, and enhancing health outcomes.
The primary classifications of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model presents a simplified depiction of lung cells and tissue on a flat surface, employed in fundamental research and preliminary substance testing. They find utility across various domains such as drug discovery, toxicology assessments, physiological investigations, as well as the advancement of three-dimensional (3D) model methodologies. These models are utilized by academic research institutions, pharmaceutical and biotechnology firms, among others.
The in vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in vitro lung model market statistics, including the in vitro lung model industry global market size, regional shares, competitors with in vitro lung model market share, detailed in vitro lung model market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro lung model industry. These in vitro lung model market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The in-vitro lung model market size has grown exponentially in recent years. It will grow from $0.44 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing prevalence of respiratory diseases, increased focus on personalized medicine, growing interest in drug repurposing, emphasis on precision medicine approaches, growing awareness of environmental health risks.
The in-vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $1.16 billion in 2029 at a compound annual growth rate (CAGR) of 21.0%. The growth in the forecast period can be attributed to drug development needs, rise in preclinical testing, increasing awareness of respiratory toxicology, focusing on regenerative medicine, growing environmental concerns, increasing geriatric populations. Major trends in the forecast period include increased demand for drug testing, advancements in 3D printing technology, advancements in organ-on-chip technology, integration of AI and machine learning, integration of sensors and monitoring devices, expansion of applications beyond pharmaceuticals, development of disease-specific models.
The surge in clinical studies is anticipated to drive growth in the in vitro lung model market in the future. Clinical trials are investigations that evaluate the effectiveness of new medical approaches in human subjects. This increase in clinical studies is propelled by the growing demand for advanced medical treatments, rising healthcare needs, and the search for innovative solutions to complex health challenges. In vitro lung models play a crucial role in clinical trials by providing a controlled setting to examine how substances affect lung tissue, aiding in drug testing, assessing toxicity, modeling diseases, and understanding disease mechanisms. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, as of January 2024, there were 477,230 registered clinical trials globally, up from 437,508 in 2022. Consequently, the rise in clinical studies stimulates the in vitro lung model market.
Key players in the in vitro lung model market are developing 3D respiratory tissue models to enhance the physiological relevance and complexity of their models. These models are created by culturing selected respiratory cells in a specialized environment, allowing them to form a three-dimensional structure that mimics the function and morphology of the respiratory system. This provides a more physiologically relevant platform for research and drug testing. For example, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. EpiNasal replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and beating cilia. The introduction of EpiNasal expands MatTek's range of 3D respiratory tissue models, offering a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.
In July 2024, Tergus Pharma, a US-based end-to-end service provider for topical pharmaceutical products, merged with MedPharm Ltd. for an undisclosed amount. This strategic merger combines the strengths of both companies, allowing them to offer a comprehensive range of services, including commercial production and serialization, formulation development, in vitro testing, and clinical manufacturing, all within a single integrated organization. The merger enhances their capabilities in developing and manufacturing hormone-based and highly potent drugs at Tergus Pharma's GMP manufacturing facility in Durham, NC. MedPharm Ltd., based in the UK, specializes in providing in vitro models that use human tissue to simulate lung and nasal delivery systems.
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH
North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In-Vitro Lung Model Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
- 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
- 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
- Subsegments:
- 1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures; Co-cultures
- 2) By Three-Dimensional (3D) Model: Spheroids; Organoids; Lung-On-A-chip Models
- Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Varian Medical Systems Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. In-Vitro Lung Model Market Characteristics
3. In-Vitro Lung Model Market Trends And Strategies
4. In-Vitro Lung Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global In-Vitro Lung Model Growth Analysis And Strategic Analysis Framework
- 5.1. Global In-Vitro Lung Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global In-Vitro Lung Model Market Growth Rate Analysis
- 5.4. Global In-Vitro Lung Model Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global In-Vitro Lung Model Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global In-Vitro Lung Model Total Addressable Market (TAM)
6. In-Vitro Lung Model Market Segmentation
- 6.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Two-Dimensional (2D) Model
- Three-Dimensional (3D) Model
- 6.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Discovery And Toxicology Studies
- Physiological Research
- Three-Dimensional (3D) Model Development
- Other Applications
- 6.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Academic Research Institutes
- Pharmaceutical And Biotechnology Companies
- Other End-Users
- 6.4. Global In-Vitro Lung Model Market, Sub-Segmentation Of Two-Dimensional (2D) Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monolayer Cell Cultures
- Co-cultures
- 6.5. Global In-Vitro Lung Model Market, Sub-Segmentation Of Three-Dimensional (3D) Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Spheroids
- Organoids
- Lung-On-A-chip Models
7. In-Vitro Lung Model Market Regional And Country Analysis
- 7.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific In-Vitro Lung Model Market
- 8.1. Asia-Pacific In-Vitro Lung Model Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China In-Vitro Lung Model Market
- 9.1. China In-Vitro Lung Model Market Overview
- 9.2. China In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India In-Vitro Lung Model Market
- 10.1. India In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan In-Vitro Lung Model Market
- 11.1. Japan In-Vitro Lung Model Market Overview
- 11.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia In-Vitro Lung Model Market
- 12.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia In-Vitro Lung Model Market
- 13.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea In-Vitro Lung Model Market
- 14.1. South Korea In-Vitro Lung Model Market Overview
- 14.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe In-Vitro Lung Model Market
- 15.1. Western Europe In-Vitro Lung Model Market Overview
- 15.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK In-Vitro Lung Model Market
- 16.1. UK In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany In-Vitro Lung Model Market
- 17.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France In-Vitro Lung Model Market
- 18.1. France In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy In-Vitro Lung Model Market
- 19.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain In-Vitro Lung Model Market
- 20.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe In-Vitro Lung Model Market
- 21.1. Eastern Europe In-Vitro Lung Model Market Overview
- 21.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia In-Vitro Lung Model Market
- 22.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America In-Vitro Lung Model Market
- 23.1. North America In-Vitro Lung Model Market Overview
- 23.2. North America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA In-Vitro Lung Model Market
- 24.1. USA In-Vitro Lung Model Market Overview
- 24.2. USA In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada In-Vitro Lung Model Market
- 25.1. Canada In-Vitro Lung Model Market Overview
- 25.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America In-Vitro Lung Model Market
- 26.1. South America In-Vitro Lung Model Market Overview
- 26.2. South America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil In-Vitro Lung Model Market
- 27.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East In-Vitro Lung Model Market
- 28.1. Middle East In-Vitro Lung Model Market Overview
- 28.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa In-Vitro Lung Model Market
- 29.1. Africa In-Vitro Lung Model Market Overview
- 29.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. In-Vitro Lung Model Market Competitive Landscape And Company Profiles
- 30.1. In-Vitro Lung Model Market Competitive Landscape
- 30.2. In-Vitro Lung Model Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
31. In-Vitro Lung Model Market Other Major And Innovative Companies
- 31.1. Epithelix
- 31.2. The Charles Stark Draper Laboratory Inc.
- 31.3. STEMCELL Technologies
- 31.4. American Type Culture Collection (ATCC)
- 31.5. BioIVT
- 31.6. InSphero
- 31.7. Emulate Inc.
- 31.8. PhoenixBio Co. Ltd.
- 31.9. Newcells Biotech
- 31.10. CN Bio Innovations Ltd.
- 31.11. Mimetas
- 31.12. Cyfuse Biomedical K.K.
- 31.13. 3D Biotek LLC
- 31.14. AlveoliX AG
- 31.15. AxoSim Technologies LLC
32. Global In-Vitro Lung Model Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The In-Vitro Lung Model Market
34. Recent Developments In The In-Vitro Lung Model Market
35. In-Vitro Lung Model Market High Potential Countries, Segments and Strategies
- 35.1 In-Vitro Lung Model Market In 2029 - Countries Offering Most New Opportunities
- 35.2 In-Vitro Lung Model Market In 2029 - Segments Offering Most New Opportunities
- 35.3 In-Vitro Lung Model Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
